ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
China Medical System Holdings Ltd (PK)

China Medical System Holdings Ltd (PK) (CHSYF)

1,5683
0,00
(0,00%)
Geschlossen 11 Juli 10:00PM

China Medical System Holdings Ltd (PK) (CHSYF) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
1,5683
( - )
Gebot
1,06
Fragen
2,06
Volumen
-
Durchschnittliches Volumen (3 Mio.)
US$ 5.809.930
Finanzvolumen
-
0,00 Tagesbereich 0,00
1,35 52-Wochen-Bereich 1,6358
Marktkapitalisierung
Unternehmenswert
20,55B
Handelsende
1,5683
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
8,21B
Nettogewinn (LTM)
1,49B
Ausgegebene Aktien
2.420.501.512
Streubesitz (%)
51,46%
Institutioneller Besitz (%)
21,60%
Dividendenrendite (LTM)
0,29
Kurs-Gewinn-Verhältnis
17,12
Kurs-Umsatz-Verhältnis (KUV)
3,11
Gewinn pro Aktie (EPS)
0,62
Beta
1,08

Über China Medical System Holdings Ltd (PK)

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam na... China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate depression. It also provides gastroenterology products, such as METOJECT, a methotrexate injection to treat severe recalcitrant disabling psoriasis and rheumatoid arthritis; LUMEBLUE, a methylthioninium chloride enteric-coated sustained-release tablets for colorectal lesion visualization; Salofalk for ulcerative colitis and Crohn’s disease; Bioflor, a saccharomyces boulardii sachets for diarrhea; Combizym and Cidine for digestive enzymes; and Ursofalk, a ursodeoxycholic acid capsules to treat cholesterol gallstones. In addition, the company offers dermatology products, including ILUMETRI, a tildrakizumab injection for the treatment of plaque psoriasis; Aethoxysklerol, a polidocanol injection for sclerotherapy of various varicose veins; Hirudoid, a mucopolysaccharide polysulfate cream to treat blunt traumata; skin heling soothing product; and Hirudoid for acne-prone skin care, prevention, and enhancement of acne. Further, it provides Vmonalisa, modified sodium hyaluronate filler for mid to deep dermal implantation; augentropfen stulln mono eye drops for asthenopia; EyeOP1 glaucoma treatment device; and Elcitonin for Osteoporosis pain. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. Mehr anzeigen

Sektor
-
Branche
-
Website
Hauptsitz
North Point, Hong Kong
Gegründet
1995
China Medical System Holdings Ltd (PK) is listed in the sector of the OTC Markets with ticker CHSYF. The last closing price for China Medical System (PK) was US$1,57. Over the last year, China Medical System (PK) shares have traded in a share price range of US$ 1,35 to US$ 1,6358.

China Medical System (PK) currently has 2.420.501.512 shares in issue. The market capitalisation of China Medical System (PK) is US$3,80 billion. China Medical System (PK) has a price to earnings ratio (PE ratio) of 17.12.

CHSYF Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
4001.568251.568251.568253001.56825CS
120.2182516.16666666671.351.568251.35751.56825CS
260.2182516.16666666671.351.568251.35501.56825CS
52-0.06755-4.129477931291.63581.63581.355161.5328207CS
1560.050253.310276679841.5181.63580.93077081.23790194CS
260-0.83175-34.656252.42.44420.9307117571.87892013CS

CHSYF - Frequently Asked Questions (FAQ)

What is the current China Medical System Holdings Ltd (PK) share price?
The current share price of China Medical System Holdings Ltd (PK) is US$ 1,5683
How many China Medical System Holdings Ltd (PK) shares are in issue?
China Medical System Holdings Ltd (PK) has 2.420.501.512 shares in issue
What is the market cap of China Medical System Holdings Ltd (PK)?
The market capitalisation of China Medical System Holdings Ltd (PK) is USD 3,8B
What is the 1 year trading range for China Medical System Holdings Ltd (PK) share price?
China Medical System Holdings Ltd (PK) has traded in the range of US$ 1,35 to US$ 1,6358 during the past year
What is the PE ratio of China Medical System Holdings Ltd (PK)?
The price to earnings ratio of China Medical System Holdings Ltd (PK) is 17,12
What is the cash to sales ratio of China Medical System Holdings Ltd (PK)?
The cash to sales ratio of China Medical System Holdings Ltd (PK) is 3,11
What is the registered address of China Medical System Holdings Ltd (PK)?
The registered address for China Medical System Holdings Ltd (PK) is Island Place Tower, North Point
What is the China Medical System Holdings Ltd (PK) website address?
The website address for China Medical System Holdings Ltd (PK) is web.cms.net.cn/zh/home/

CHSYF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen